title: The role of cAMP and its downstream targets in neurite growth in the adult nervous system.
abstract: Injured neurons in the adult mammalian central nervous system (CNS) have a very limited capacity for axonal regeneration and neurite outgrowth. This inability to grow new axons or to regrow injured axons is due to the presence of molecules that inhibit axonal growth, and age related changes in the neuron's innate growth capabilities. Available levels of cAMP are thought to have an important role in linking both of these factors. Elevated levels of cAMP in the developing nervous system are important for the guidance and stability of growth cones. As the nervous system matures, cAMP levels decline and the growth promoting effects of cAMP diminish. It has frequently been demonstrated that increasing neuronal cAMP can enhance neurite growth and regeneration. Some methods used to increase cAMP include administration of cAMP agonists, conditioning lesions, or electrical stimulation. Furthermore, it has been proposed that multiple stages of cAMP induced growth exist, one directly caused by its downstream effector Protein Kinase A (PKA) and one caused by the eventual upregulation of gene transcription. Although the role cAMP in promoting axon growth is well accepted, the downstream pathways that mediate cAMP-mediated axonal growth are less clear. This is partly because various key studies that explored the link between PKA and axonal outgrowth relied on the PKA inhibitors KT5720 and H89. More recent studies have shown that both of these drugs are less specific than initially thought and can inhibit a number of other signalling molecules including the Exchange Protein Activated by cAMP (EPAC). Consequently, it has recently been shown that a number of intracellular signalling pathways previously attributed to PKA can now be attributed solely to activation of EPAC specific pathways, or the simultaneous co-activation of PKA and EPAC specific pathways. These new studies open the door to new potential treatments for repairing the injured spinal cord.
authors.affiliation: Neuroscience and Mental Health Institute, 3-88 Corbett Hall, University of Alberta, Edmonton, AB T6E 2G4, Canada.
authors.forename: Nicholas J
authors.initials: NJ
authors.lastname: Batty
authors.affiliation: Neuroscience and Mental Health Institute, 3-88 Corbett Hall, University of Alberta, Edmonton, AB T6E 2G4, Canada; Department of Physical Therapy, 3-88 Corbett Hall, University of Alberta, Edmonton, AB T6E 2G4, Canada.
authors.forename: Keith K
authors.initials: KK
authors.lastname: Fenrich
authors.affiliation: Neuroscience and Mental Health Institute, 3-88 Corbett Hall, University of Alberta, Edmonton, AB T6E 2G4, Canada; Department of Physical Therapy, 3-88 Corbett Hall, University of Alberta, Edmonton, AB T6E 2G4, Canada. Electronic address: karim.fouad@ualberta.ca.
authors.forename: Karim
authors.initials: K
authors.lastname: Fouad
mesh_terms: D000818:Animals; D002490:Central Nervous System / Q000293:injuries / Q000378:metabolism* / Q000648:ultrastructure; D000242:Cyclic AMP / Q000378:metabolism*; D017868:Cyclic AMP-Dependent Protein Kinases / Q000378:metabolism; D004558:Electric Stimulation; D006801:Humans; D009414:Nerve Growth Factors / Q000378:metabolism; D009416:Nerve Regeneration; D016501:Neurites / Q000502:physiology*; D013119:Spinal Cord Injuries / Q000378:metabolism / Q000473:pathology / Q000628:therapy
chemical_list: D009414:Nerve Growth Factors; D000242:Cyclic AMP; D017868:Cyclic AMP-Dependent Protein Kinases
keywords: EPAC; EPAC2; Molecular signalling; PKA; Spinal cord injury